Delivery Order SPE2DB25D3110-SPE2DB25FTEHX
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order for M-M-R II vaccine vials valued at $3,269.25 on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order was issued under a competitively awarded, non-set-aside procurement by the Medical Supply Chain, a defense-focused federal agency supporting military and veteran healthcare systems. The contract represents...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $15,679.50 by the Defense Logistics Agency (DLA) for M-M-R II vaccine vials, with an ultimate completion date of August 12, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award status. Performance will be executed at the contractor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 11, 2025, for M-M-R II vaccine vials with a ceiling value of $2,330.79. This firm fixed-price delivery order, which is not associated with any set-aside designation, is expected to be completed by August 12, 2025, and will be performed at the contractor's Conshohocken facility. The award represents a routine...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $1,119.10 by the Defense Logistics Agency (DLA) for M-M-R II vaccine vials. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 5, 2025, and represents a continuation of the company's extensive pharmaceutical supply relationship with DLA. The award carries no set-aside designation and will be performed at the vendor's corporate office...
- The Defense Logistics Agency awarded a $1,039.69 firm fixed price delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of September 10, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive pharmaceutical supply agreement valued at $999,999,999.00 through December 2026. The contract will be performed at...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,119.10 by the Defense Logistics Agency (DLA) on August 11, 2025, with an ultimate completion date of August 12, 2025. The delivery order is for M-M-R II vaccine vials to be performed at the company's corporate office location in Conshohocken, Pennsylvania. This is a firm fixed-price, non-set-aside contract awarded through open competition, structured as a child contract under a larger vehicle. AmerisourceBergen Drug Corp, a...
- The Defense Logistics Agency awarded a $4,685.90 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of M-M-R II vaccine vials. The contract utilizes firm fixed pricing with an ultimate completion date of August 11, 2025, and represents a non-set-aside competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $4,511.07 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of July 23, 2025. This firm fixed price contract, issued on July 22, 2025, represents a non-competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, where the company serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of M-M-R II vaccine vials, with a ceiling value of $4,185.90. This competitively awarded, firm fixed-price contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The performance location is AmerisourceBergen's corporate headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $4,772.92 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's...
- SPE2DB25D3110Indefinite Delivery Contract
- SPE2DB25D3110-SPE2DB25FTEHXDelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency for M-M-R II vaccine vials valued at $4,069.61 with a firm fixed price structure. The award was made on September 9, 2025, with an ultimate completion date of September 10, 2025, and was not designated as a set-aside contract. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which carries a potential value of $999,999,999.00 and extends through December 2026. The DLA Troop Support Medical IDC serves as a comprehensive pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. This prime contract encompasses specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard. The M-M-R II vaccine vial delivery under this award supports the federal government's medical supply needs within the military healthcare system, consistent with AmerisourceBergen's role as a critical vendor for federal medical procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 9/9/25 |